196 related articles for article (PubMed ID: 36310703)
21. Relations of Changes in Serum Carcinoembryonic Antigen Levels before and after Neoadjuvant Chemoradiotherapy and after Surgery to Histologic Response and Outcomes in Patients with Locally Advanced Rectal Cancer.
Saito G; Sadahiro S; Ogimi T; Miyakita H; Okada K; Tanaka A; Suzuki T
Oncology; 2018; 94(3):167-175. PubMed ID: 29268274
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
[TBL] [Abstract][Full Text] [Related]
23. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in patients with complete response of the tumour (ypT0) after neoadjuvant chemoradiotherapy and radical resection of rectal cancer.
Zhang H; Sun G; Zheng K; Lou Z; Gao XH; Meng RG; Furnée EJB; Zhang W
ANZ J Surg; 2021 Apr; 91(4):E190-E195. PubMed ID: 33559307
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of mesorectal package area in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A retrospective cohort study.
Guan B; Huang X; Xia H; Guan G; Xu B
Front Oncol; 2022; 12():941786. PubMed ID: 36263216
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
Cheong C; Shin JS; Suh KW
World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
[TBL] [Abstract][Full Text] [Related]
27. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824
[No Abstract] [Full Text] [Related]
28. Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer.
Yoo GS; Park HC; Yu JI; Choi DH; Cho WK; Park YS; Park JO; Lim HY; Kang WK; Lee WY; Kim HC; Yun SH; Cho YB; Park YA; Song KD; Kim SH; Ha SY
Cancer Res Treat; 2020 Apr; 52(2):446-454. PubMed ID: 31588705
[TBL] [Abstract][Full Text] [Related]
29. Elevated CA19-9 as the Most Significant Prognostic Factor in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy.
Zhang LN; OuYang PY; Xiao WW; Yu X; You KY; Zeng ZF; Xu RH; Gao YH
Medicine (Baltimore); 2015 Nov; 94(45):e1793. PubMed ID: 26559251
[TBL] [Abstract][Full Text] [Related]
30. C-Reactive Protein as Predictive Biomarker for Response to Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Retrospective Study.
Aires F; Rodrigues D; Lamas MP; Herdeiro MT; Figueiras A; Oliveira MJ; Marques M; Pinto AT
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158759
[TBL] [Abstract][Full Text] [Related]
31. Stage cT3 low rectal cancer: analysis of prognostic factors.
Li F; Chen JH; Liu Y; Guan GX; Lu CH
J Gastrointest Oncol; 2022 Apr; 13(2):672-682. PubMed ID: 35557560
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
Zhang Y; Liu X; Xu M; Chen K; Li S; Guan G
Sci Rep; 2020 May; 10(1):8017. PubMed ID: 32415197
[TBL] [Abstract][Full Text] [Related]
33. [Application of preoperative serum CYFRA 21-1 level in the prognosis of colorectal cancer].
Hu WQ; Cong H; Fang RH; Yuan WT; Mao CY; Wang JR; Wang Y; Shi XY
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Oct; 57(10):1613-1619. PubMed ID: 37859379
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopathological and prognostic features of young onset patients with middle-low rectal cancer received neoadjuvant chemoradiotherapy].
Zhang QQ; Wu YL; Li DD; Shen SH; Fang H; Zhu YL; Zhang HZ
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):574-580. PubMed ID: 34034478
[No Abstract] [Full Text] [Related]
35. Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer.
Hermunen K; Soveri LM; Boisen MK; Mustonen HK; Dehlendorff C; Haglund CH; Johansen JS; Osterlund P
Acta Oncol; 2020 Dec; 59(12):1416-1423. PubMed ID: 32790589
[TBL] [Abstract][Full Text] [Related]
36. High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy.
Zhou W; Yang F; Peng J; Wang F; Lin Y; Jiang W; Yang X; Li L; Lu Z; Wan D; Pan Z; Fan W
J Cancer; 2019; 10(16):3810-3818. PubMed ID: 31333798
[TBL] [Abstract][Full Text] [Related]
37. Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.
Xu H; You G; Zhang M; Song T; Zhang H; Yang J; Jia Y; Tang J; Liang X
World J Surg Oncol; 2019 Nov; 17(1):199. PubMed ID: 31785609
[TBL] [Abstract][Full Text] [Related]
38. [Predictive value of preoperative detection of CEA and CA199 for prognosis in patients with stage II-III colorectal cancer].
Chen L; Jiang B; Di J; Zhang C; Wang Z; Zhang N; Xing J; Cui M; Yang H; Yao Z; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):914-9. PubMed ID: 26404690
[TBL] [Abstract][Full Text] [Related]
39. Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis.
Lin PC; Lin JK; Lin CC; Wang HS; Yang SH; Jiang JK; Lan YT; Lin TC; Li AF; Chen WS; Chang SC
Int J Colorectal Dis; 2012 Oct; 27(10):1333-8. PubMed ID: 22426691
[TBL] [Abstract][Full Text] [Related]
40. Normalization of CEA Levels Post-Neoadjuvant Therapy is a Strong Predictor of Pathologic Complete Response in Rectal Cancer.
Kleiman A; Al-Khamis A; Farsi A; Kezouh A; Vuong T; Gordon PH; Vasilevsky CA; Morin N; Faria J; Ghitulescu G; Boutros M
J Gastrointest Surg; 2015 Jun; 19(6):1106-12. PubMed ID: 25859755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
